Clinical Trials on Infections à Corynebacterium

Total 56358 results

Centre Hospitalier Intercommunal de Toulon La Seyne...
Centre d'Epidémiologie et de Santé Publique des Armées

Completed

Cutaneous Diphtheria in France : Observational, Retrospective Study of Patient Characteristics (OEDIPE)

Corynebacterium Diphtheriae Infection

France
Hospices Civils de Lyon

Completed

Corynebacterium Spp Bone and Joint Infection: Retrospective Study of Microbiological, Diagnostic and Therapeutic Features

Corynebacterium Infections

France
Bornova No. 25 Mevlana Family Health Center

Completed

The Effect of ShotBlocker on Injection Pain

Pain | Intramuscular Injection

Turkey
Novartis Vaccines

Completed

Immunogenicity and Safety of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 13-59 Months Old Healthy Children

Haemophilus Influenzae Type b (Hib) Infection

China
MassBiologics

Completed

Evaluate the Safety Pharmacokinetics of a Human Monoclonal Antibody S315 Against Diphtheria Toxin in Healthy Subjects (S315)

Diphtheria

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age

Meningitis | Meningococcal Infection

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
StemlineTherapeutics, Inc.

Recruiting

Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients With Relapsed/Refractory AML (GO-TAG)

Acute Myeloid Leukemia

United States
GlaxoSmithKline

Completed

A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.

Diphtheria

Brazil
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents

Meningitis | Meningococcemia

United States
Hasan Kalyoncu University

Not yet recruiting

Vibration and Shotblocker Use in Pregnant Women While Giving Tetanus + Diphtheria Vaccine

Pain

Turkey
Boryung Biopharma Co., Ltd.

Completed

To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children

Tetanus | Diphtheria

Korea, Republic of
PT Bio Farma

Completed

Post Marketing Surveillance of Diphtheria Antitoxin (DAT)

Safety Issues

Indonesia
Sanofi Pasteur, a Sanofi Company

Completed

Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children

Meningitis | Meningococcemia

United Kingdom
Sanofi Pasteur, a Sanofi Company

Completed

Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine

Meningitis | Neisseria Meningitidis | Meningococcemia

United States
Biomat USA, Inc.
Axio Research. LLC; Hammond Clinical Trial Consulting, LLC

Completed

Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program

Healthy

United States
Novartis Vaccines

Completed

Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in China

Haemophilus Influenzae Type b (Hib) Infection

China
Centers for Disease Control and Prevention
Emory University

Completed

Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine

Pneumococcal Infections

United States
Sanofi Pasteur, a Sanofi Company

Completed

Retrospective Survey of Safety of Fourth Dose Pentacel® in Children

Pertussis | Tetanus | Diphtheria | Polio | Haemophilus Infection

Canada
Sanofi

Completed

Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™

Pertussis | Tetanus | Diphtheria | Polio | Haemophilus Infection

United States
GlaxoSmithKline

Completed

Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9

Tetanus | Diphtheria | Acellular Pertussis

United States
GlaxoSmithKline

Completed

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

Tetanus | Diphtheria | Acellular Pertussis

United States
Medical University of Warsaw
Medical University of Silesia; Poznan University of Medical Sciences; Wroclaw...

Completed

Diphtheria Vaccination in Adolescents With Inflammatory Bowel Disease

Diphtheria | Inflammatory Bowel Diseases
GlaxoSmithKline

Completed

Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults

Tetanus | Diphtheria | Acellular Pertussis

United States
GlaxoSmithKline

Completed

Evaluation of Boostrix™10 Years After Previous Booster Vaccination

Tetanus | Diphtheria | Acellular Pertussis

Belgium
GlaxoSmithKline

Completed

Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV)

Tetanus | Diphtheria | Acellular Pertussis

Spain, Netherlands, Belgium
GlaxoSmithKline

Terminated

Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.

Tetanus | Diphtheria | Acellular Pertussis

Australia
Bandim Health Project
Aarhus University Hospital; Rigshospitalet, Denmark

Completed

Randomized Study of Not Giving Diphteria-tetanus-pertussis Vaccination With or After Measles Vaccination

Mortality | Hospitalization | Adverse Events

Guinea-Bissau
Statens Serum Institut

Completed

Immunogenicity and Safety of Tetanus, Diphtheria and Mono Component Acellular Pertussis (TdaP) Vaccine in Comparison to Tetanus and Diphtheria (Td) Vaccine When Given as Booster Vaccinations to Adults

Healthy

Denmark
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd

Recruiting

Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants

Healthy Volunteers

China
CanSino Biologics Inc.

Recruiting

A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)

Pertussis | Tetanus | Diphtheria

China
Atlanta VA Medical Center
Emory University; General Services Administration (GSA)

Completed

Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System

Pneumonia | Pertussis | Tetanus | Diphtheria | Influenza

United States
GlaxoSmithKline

Completed

Post Market Surveillance for Infanrix™

Tetanus | Diphtheria | Acellular Pertussis

Korea, Republic of
GlaxoSmithKline

Completed

Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants

Tetanus | Diphtheria | Acellular Pertussis

Korea, Republic of
GlaxoSmithKline

Completed

Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents

Tetanus | Diphtheria | Acellular Pertussis

Mexico, Chile
GlaxoSmithKline

Completed

Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children

Tetanus | Diphtheria | Acellular Pertussis

Vietnam
GlaxoSmithKline

Completed

Study to Assess Safety & Immunogenicity of GSK Biologicals' DTPa/Hib Vaccine vs Separate Administration of DTPa and Hib.

Tetanus | Diphtheria | Acellular Pertussis

China
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults

Tetanus | Diphtheria | Acellular Pertussis

United States
GlaxoSmithKline

Completed

Study to Assess the Safety & Reactogenicity of GSK Biologicals' dTpa Vaccine (Boostrix) When Given at 6-8 Years of Age.

Tetanus | Diphtheria | Acellular Pertussis

China
GlaxoSmithKline

Completed

Duration of Protection: GSK DTaP Vaccines

Tetanus | Diphtheria | Acellular Pertussis
GlaxoSmithKline

Completed

A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers

Diphtheria

Spain, Germany, Italy
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children

Tetanus | Diphtheria | Acellular Pertussis

China
Clifford Craig Medical Research Trust
Johns Hopkins Bloomberg School of Public Health; Monash University; University... and other collaborators

Unknown

Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly

Heterologous Effects of Vaccines

Australia
GlaxoSmithKline

Completed

Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine

Tetanus | Diphtheria | Acellular Pertussis

China
GlaxoSmithKline

Completed

Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety

Tetanus | Diphtheria | Acellular Pertussis

United States
Hillel Yaffe Medical Center

Recruiting

Immune Response followingTdap Vaccine in Pregnancy

Diphtheria-Tetanus-acellular Pertussis Vaccines

Israel
Aga Khan University
University of British Columbia; Grand Challenges Canada

Unknown

Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan

Hepatitis B | Pertussis | Tetanus | Diphtheria | Tuberculosis | Polio | Pneumococcal Infection | Haemophilus Influenzae Type b Infection
IBSS Biomed S.A.

Active, not recruiting

Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria. (Clodivac)

Tetanus | Diphtheria

Poland
Sanofi Pasteur, a Sanofi Company

Completed

Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td

Tetanus | Diphtheria

United States
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women

Diphtheria-Tetanus-acellular Pertussis Vaccines

Finland, Australia, Spain, Italy, Canada, Czechia
Korea University Guro Hospital

Completed

Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine

Pneumococcal Infections | Tetanus | Diphtheria

3

Subscribe